The 2020 Circular Economy Action Plan is one of the main blocks of the European Green Deal – Europe’s new agenda for sustainable growth – including initiatives along the entire life cycle of products and aiming at rendering sustainable products the norm in the EU. It focuses on boosting circular economy processes, fostering sustainable consumption, and safeguarding that the resources used are kept in the economy for as long as possible. In addition, it remains committed to making circularity work for people, regions, and cities, while leading global efforts on circular economy.
At the same time, and closely linked with the above, the bioeconomy offers great potential in contributing to tackle environmental and societal challenges, such as resource efficiency, climate change, maintaining European competitiveness and job creation. The bioeconomy can therefore play a significant role in the EU Green Deal and particularly in the transition to a circular economy, as outlined in a position paper developed by the European Bioeconomy Alliance. As a result, this webinar aspires to address the above developments by providing an opportunity for discussion of how to best empower the circular bioeconomy through an enabling policy framework.
Event hosted by MEP Franc Bogovič, Chair of the Bioeconomy Working Group of the European Parliament Intergroup on ‘Climate Change, Biodiversity and Sustainable Development’.
+32(0)2 230 30 70
ebcd.info@ebcd.org
VIRTUAL EVENT
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.